Next Generation, Modifiable Cardiometabolic Biomarkers: Mitochondrial Adaptation and Metabolic Resilience
Published: October 30, 2023

- Research advances in multi-omic technologies are broadening our understanding of the molecular mechanisms that underpin metabolic health across the lifespan.
- ‘Omic’ biomarkers promise to identify the earliest departure from healthy metabolism, which may be very early in life when therapeutic interventions may prove more successful.
- This statement explores emerging biomarkers of cardiometabolic risk across five interconnected ‘omic’ domains that may serve as leading-edge indicators to detect the earliest departure from healthy metabolism and track returns to healthy metabolism with intervention.
Supporting Materials
Recommended Reading
- Heart Disease and Stroke Statistics—2022 Update
- Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment
- Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth
- Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure